12:00 AM
 | 
Feb 16, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Volinanserin: Development discontinued

sanofi-aventis discontinued development of volinanserin, which was in Phase III testing. The company did not...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >